HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Julian Downward Selected Research

Bortezomib (Velcade)

6/2015RAS mutation status and bortezomib therapy for relapsed multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Julian Downward Research Topics

Disease

56Neoplasms (Cancer)
04/2024 - 08/2002
17Lung Neoplasms (Lung Cancer)
04/2024 - 05/2013
10Neoplasm Metastasis (Metastasis)
05/2024 - 01/2002
10Carcinogenesis
12/2023 - 08/2002
8Adenocarcinoma of Lung
04/2024 - 05/2014
8Breast Neoplasms (Breast Cancer)
11/2020 - 01/2008
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2023 - 09/2003
4Melanoma (Melanoma, Malignant)
01/2023 - 01/2012
3Chromosomal Instability (Chromosome Stability)
02/2012 - 04/2006
3Ovarian Neoplasms (Ovarian Cancer)
05/2009 - 06/2007
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2006 - 04/2002
2Triple Negative Breast Neoplasms
11/2020 - 01/2020
2Renal Cell Carcinoma (Grawitz Tumor)
10/2018 - 08/2010
2Polyploidy
02/2012 - 06/2007
2Colorectal Neoplasms (Colorectal Cancer)
03/2011 - 04/2006
2Parkinson Disease (Parkinson's Disease)
03/2009 - 11/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
10/2008 - 11/2007
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2024
1Lung Diseases (Lung Disease)
01/2021
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Adenocarcinoma
01/2019
1Kidney Neoplasms (Kidney Cancer)
10/2018
1Hyperplasia
11/2016
1Multiple Hamartoma Syndrome (Cowden's Disease)
11/2016

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
08/2023 - 09/2003
9Phosphotransferases (Kinase)IBA
01/2021 - 08/2007
8ErbB Receptors (EGF Receptor)IBA
12/2023 - 06/2015
7ras ProteinsIBA
08/2023 - 12/2008
7Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
12/2018 - 12/2009
6Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2019 - 03/2011
5Phosphatidylinositols (Phosphatidylinositol)IBA
07/2013 - 06/2007
4Immune Checkpoint InhibitorsIBA
04/2024 - 01/2022
4Protein Isoforms (Isoforms)IBA
10/2021 - 01/2010
4Paclitaxel (Taxol)FDA LinkGeneric
02/2012 - 06/2007
4Transforming Growth Factor beta (TGF-beta)IBA
12/2007 - 01/2002
3DNA (Deoxyribonucleic Acid)IBA
10/2022 - 07/2007
3Tyrosine Kinase InhibitorsIBA
01/2021 - 05/2013
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 05/2014
3Estrogen ReceptorsIBA
09/2014 - 05/2009
3Small Interfering RNA (siRNA)IBA
05/2014 - 08/2010
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2006 - 04/2002
2Messenger RNA (mRNA)IBA
12/2023 - 12/2017
2AntibodiesIBA
01/2023 - 06/2015
2Cadherins (E-Cadherin)IBA
01/2021 - 01/2019
2osimertinibIBA
01/2021 - 01/2018
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020 - 05/2013
2Glutathione (Reduced Glutathione)IBA
10/2018 - 01/2016
2Carrier Proteins (Binding Protein)IBA
12/2017 - 06/2007
2Tyrosine (L-Tyrosine)FDA Link
11/2016 - 12/2011
2Proteasome Endopeptidase Complex (Proteasome)IBA
04/2015 - 08/2012
2MicroRNAs (MicroRNA)IBA
01/2014 - 01/2008
2Epidermal Growth Factor (EGF)IBA
09/2012 - 06/2002
2Biomarkers (Surrogate Marker)IBA
03/2012 - 08/2010
2CeramidesIBA
02/2012 - 06/2007
2taxaneIBA
05/2009 - 04/2006
2Cytotoxins (Cytolysins)IBA
08/2007 - 06/2007
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
04/2007 - 05/2006
1TransferasesIBA
05/2024
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
04/2024
1Dinoprostone (PGE2)FDA Link
04/2024
1ApolipoproteinsIBA
12/2023
1EnzymesIBA
12/2023
1Glycoproteins (Glycoprotein)IBA
01/2023
1Fc Receptors (Fc Receptor)IBA
01/2023
1Immunoglobulin E (IgE)IBA
01/2023
1AntigensIBA
01/2023
1chondroitin sulfate proteoglycan 4IBA
01/2023
1Particulate MatterIBA
01/2023
1Air Pollutants (Pollutants, Air)IBA
01/2023
1Cytosine DeaminaseIBA
10/2022
1InterferonsIBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2021
1trovafloxacinIBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
11/2020
1human ERBB2 proteinIBA
11/2020
1Ribosomal Protein S6IBA
01/2020
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019
1Sodium-Glucose Transporter 1IBA
01/2019
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2019
1Codon (Codons)IBA
01/2019
1ARS-1620IBA
01/2019
1Serum Response FactorIBA
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Insulin-Like PeptidesIBA
01/2019
1Fatty Acids (Saturated Fatty Acids)IBA
10/2018
1Trastuzumab (Herceptin)FDA Link
01/2018
1Monoclonal AntibodiesIBA
01/2018
1Cetuximab (Erbitux)FDA Link
01/2018
1TristetraprolinIBA
12/2017
1thiamine triphosphorate (TTP)IBA
12/2017
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
11/2016
1Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
11/2016

Therapy/Procedure

16Therapeutics
12/2023 - 01/2003
8Immunotherapy
04/2024 - 01/2020
4Drug Therapy (Chemotherapy)
01/2022 - 06/2007
1Isogeneic Transplantation
10/2022